
|Videos|November 16, 2021
Dr. Bander gives an overview of PSMA-PET imaging innovations
Author(s)Urology Times staff
“It's very clear that PSMA-PET imaging is having…a transformative impact on our ability to image metastatic disease, in that it is much more sensitive than we've had for the last 50 plus years—and also, 98% specific,” says Neil H. Bander, MD.
Advertisement
In this video, Neil H. Bander, MD, discusses innovations in PSMA-PET imaging for patients with prostate cancer and how these breakthroughs will change diagnosis and treatment. Bander is the Bernard & Josephine Chaus professor of Urologic Oncology at Weill Cornell Medicine, New York City, New York.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
Phase 1/2 trial launches of molecular glue degrader for ccRCC
5






